The NIH Catalyze program empowers innovators to fast-track heart, lung, blood, and sleep (HLBS) discoveries toward real-world impact. Offering up to $1M/year, it supports Product Definition grants (R61/R33) and Preclinical Services, tailored to your stage of development.
Who Can Apply?
Catalyze welcomes a broad range of U.S.-based organizations:
- Higher education institutions
- Non-profits and for-profits (including small businesses)
- State, local, tribal governments, and community-based organizations
- HBCUs, AANAPISIs, and more
A qualified PD/PI is required, and diverse candidates are strongly encouraged.
How CTC Supports You
The Center for Technology Commercialization is your partner in success:
- Write key areas of your application to ensure clarity and competitiveness
- Strategize your proposal, including milestones and development plans
- Offer technical and regulatory expertise, FDA strategy, and commercialization support
- Connect you with experts and provide cohort-based learning opportunities
📅 Key Deadlines
- Product Definition (R61/R33): Apply by Feb 11
- Preclinical Services EOI: Jan 26–Feb 13
Ready to advance your discovery? Email us today and learn more at nhlbicatalyze.org/faq.
